DUBLIN-- ( BUSINESS WIRE )-- ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the third quarter ended ...

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast ...

ICON plc (ICLR) stock traded lower after the company cut its guidance with its Q3 results, leading to a selloff in rival ...

Organizational success starts with being able to measure the right customer experience (CX) metrics. Identifying where and ...

Truist analyst Jailendra Singh lowered the firm’s price target on Icon (ICLR) to $295 from $363 and keeps a Buy rating on the shares.

A's classic sandwich were similar, but the cheaper version from McDonald's came out on top.

Here are four ways to help solve shopping cart abandonment and create enjoyable, repeatable and fulfilled customer journeys.

Discover how Starbucks’ Red Cup Day became a beloved holiday tradition, creating seasonal excitement, community connection, ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on ICLR stock, giving a Buy rating today. Ann Hynes has given her Buy ...

Strella, an AI-powered market research startup, raises $4 million in seed funding to automate and accelerate customer ...

At a recent trade event, Harry Sommer shared some research that many Royal Caribbean passengers may disagree with.

Optimizing the Use of Marketing Technology to Build Customer Trust Webinar Featuring Alex Clemente, Managing Director, ...